EOLPodcast

Ep. 331 Looking Ahead to 2022

Learn how the innovations of the past year are going to create more positive change in 2022!

In this final episode of 2021 I’ll share with you some of the innovations of 2021 that are going to be driving further change in the coming year. I’ll remind you of some of the conversations from this past year that provide potential solutions to the issues we are currently facing around end-of-life care. And we’ll recognize that amidst all the pain and sorrow of this pandemic year there has been much to be grateful and joyful about! (This episode is overflowing with information so keep a pen and paper handy to make note of interviews you may want to hear!)

Listen here:

This episode includes:

Links mentioned in this episode:

If you enjoy this content please share it with others and consider leaving a review on iTunes. Thanks again to all supporters on my page at Patreon.com/eolu, especially my new patrons Teri A. Portugal Gooden and Cari Zlotnick; and thank you Brittany Ellis for increasing your monthly pledge! Your contributions make all the difference.

EOLPodcast

Ep. 295 Psilocybin Therapy at End of Life: The Legal Case with Kathryn Tucker, JD

Learn about the legal effort to make psilocybin available as a transformative therapy at the end of life.

My guest Kathryn Tucker is a Special Counsel at Emerge Law Group where she co-chairs the Psychedelic Practice Group. She is also the Executive Director of the End-of-Life Liberty Project and served two decades as Director of Advocacy and Legal Affairs for Compassion & Choices, working to improve care and expand choice at the end of life. She shares the current legal case she is spearheading to allow terminally ill patients to try psilocybin as a palliative care medication and how psilocybin has already been shown to be hugely beneficial to patients at the end of life. Learn more about her work at:

www.emergelawgroup.com

Listen here:

This episode includes:

  • The benefits of psilocybin therapy for palliative care
  • Why terminally ill patients cannot currently access psilocybin therapy
  • What are Right to Try (RTT) laws and how they may apply to psilocybin
  • History behind psilocybin being labeled a Schedule I drug by the DEA
  • Test case that has been filed in court based on Washington state and Federal RTT laws
  • How “friends of the court” can be helpful to this case
  • Why the success of this case could open access for patients in other states
  • Oregon’s Psilocybin Therapy Law and implications for other states

Links mentioned in this episode:

If you enjoy this content please share it with others and consider leaving a review on iTunes! Thanks again to all supporters on my page at Patreon.com/eolu! Your contributions make all the difference!